Neuro-navigation also called frameless stereotactic surgery which involves performing real-time intraoperative guidance during spinal/brain injuries. This system enhances safety and accuracy during neurosurgical procedures and helps surgeons achieve surgical targets without the need for external. Neuro-navigation systems are primarily used in brain surgery to limit the size of the cranial opening or craniotomy, and help remove deep brain lesions. It also assists psychiatrists to precisely target rTMS (Transcranial Magnetic Stimulation). Such factors are likely to drive the demand for the neuro-navigation systems market in the near future.
Growing incidence of neurological disorders such as cancer, benign tumors, and stroke as well as rising adoption of minimally invasive surgical procedures are the key growth drivers for the global neuro-navigation systems market. Furthermore, the demand for neuro-navigation systems is expected to grow as the number of neurosurgical procedures being performed worldwide increases. For instance, as per the American Cancer Society, in 2022 , approximately 25,050 malignant tumors of the brain or spinal cord (14,170 in men and 10,880 in women) will be diagnosed in the U.S. and around 18,280 people will die from the same illness.Thus, the rise in the number of people suffering from brain tumors and related conditions leading to brain metastasis is expected to propel the demand for neuro-navigation systems during the forecast period.
Furthermore, an increasing number of approvals and new product launches are expected to further drive the market growth over the forecast period. The introduction of new and innovative products by key market players is fuelling the demand and adoption of these systems in the global market. Advancements in technology such as improved accuracy due to improved software and registration processes, as well as the less complicated framework is expected to propel the growth of the neuro-navigation systems market. For instance,
In May 2021 , ClearPoint Neuro, Inc., announced the first human cases of the SmartFrame Array Neuro-navigation system and software.This system is designed to streamline workflows and reduce procedure time in both the MRI suite and in the operating room.
In May 2019, StimGuide TMS navigation system was launched by MagStim, to provide consistent and precise coil positioning while performing depressive disorder treatments.
Similarly, in July 2018, Medtronic announced the StealthStation S8 and the StealthStation ENT surgical navigation systems that are now approved for sale in Canada. This systemprovides enhanced visualization to surgeons and helps to precisely locate anatomical structures in either open or minimally invasive procedures like skull, spinal cord, and sinus cavities.
These technological advancements are expected to boost the neuro-navigation systems market growth over the forecast period. Key players operating in the Neuro-navigation Systems market include Northern Digital Inc., ClaroNav, Medtronic, Stryker, BrainLAB AG, Synaptive Medical, Soterix Medical Inc., Stryker, Nexstim Plc, 7D Surgical, Zimmer Biomet Holding Inc., and Parsis Co. and other players.
However, clinical complications related to neuro-navigation systems , along with the high cost of these devices and their maintenance is expected to slow market growth during the forecast period.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."